Related Experiment Video
Updated: May 2, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Investigation of melanocortin system gene variants in antipsychotic-induced weight gain
Nabilah I Chowdhury1, Renan P Souza, Arun K Tiwari
1Neurogenetics Section, Neuroscience Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto, ON , Canada.
Objectives:
The use of second-generation antipsychotic medications may result in substantial weight gain in a subset of schizophrenia patients. Distinct populations of neurons expressed in the hypothalamus, including the cocaine- and amphetamine-regulated transcript (CART), the polypeptide pro-opiomelanocortin (POMC) and the agouti-related protein (AGRP), have regulatory roles in weight control and energy homeostasis. Thus, we investigated the potential role of CART, POMC and AGRP genetic variants in antipsychotic-induced weight gain (AIWG).
Methods:
Five CART single nucleotide polymorphisms (SNPs) (rs10515115, rs3763153, rs3857384, rs11575893, rs16871471), three POMC SNPs (rs6713532, rs1047521, rs3754860) and one AGRP SNP (rs1338993), were genotyped in 218 patients treated with antipsychotics for chronic schizophrenia and evaluated for AIWG. We compared weight change (%) across genotypic groups using analysis of covariance.
Results:
None of the SNPs in POMC, CART, AGRP were significantly associated with AIWG in the refined samples stratified by ethnicity and medication treatment.
Conclusions:
In this exploratory study, we observed that POMC, CART and AGRP gene variants are not a major contributor to AIWG. However larger samples are required to completely rule out their effect on AIWG.
Insights
Genetic variants in POMC, CART, and AGRP genes do not appear to significantly contribute to antipsychotic-induced weight gain (AIWG) in schizophrenia patients. Further research with larger sample sizes is needed to definitively confirm these findings.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Second-generation antipsychotics can cause significant weight gain in schizophrenia patients.
- Hypothalamic neurons expressing CART, POMC, and AGRP play key roles in regulating body weight and energy balance.
Purpose of the Study:
- To investigate the potential association between genetic variants in CART, POMC, and AGRP genes and antipsychotic-induced weight gain (AIWG).
Main Methods:
- Genotyping of specific single nucleotide polymorphisms (SNPs) in CART, POMC, and AGRP genes in 218 chronic schizophrenia patients undergoing antipsychotic treatment.
- Analysis of covariance was used to compare weight change (%) across different genotypic groups.
Main Results:
- No significant associations were found between the studied SNPs in POMC, CART, or AGRP and AIWG.
- This lack of association remained consistent after stratifying samples by ethnicity and medication treatment.
Conclusions:
- Exploratory findings suggest that variants in POMC, CART, and AGRP genes are not major contributors to AIWG.
- Larger sample sizes are necessary to conclusively rule out the influence of these gene variants on AIWG.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Regulation of Food Intake
Antipsychotic Drugs: Typical and Atypical Agents
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants

